Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
8
RHHVF Quote, Financials, Valuation and Earnings
Last price:
$275.83
Seasonality move
:
0.11%
Day range:
$269.80 - $280.00
52-week range:
$233.12 - $340.88
Dividend yield:
3.96%
P/E ratio:
18.68x
P/S ratio:
3.27x
P/B ratio:
6.83x
Volume:
797
Avg. volume:
5.4K
1-year change:
0.12%
Market cap:
$219.8B
Revenue:
$67.3B
EPS (TTM):
$14.76
Analysts' Opinion
-
Consensus RatingRoche Holding AG has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Roche Holding AG has an estimated downside of -- from its current price of $275.83.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $275.83.
Fair Value
-
According to the consensus of 0 analysts, Roche Holding AG has -- downside to fair value with a price target of -- per share.
RHHVF vs. S&P 500
-
Over the past 5 trading days, Roche Holding AG has underperformed the S&P 500 by -7.32% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Roche Holding AG does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Roche Holding AG has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Roche Holding AG reported revenues of --.
Earnings Growth
-
Roche Holding AG has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Roche Holding AG reported earnings per share of --.
Enterprise value:
252.7B
EV / Invested capital:
--
Price / LTM sales:
3.27x
EV / EBIT:
15.81x
EV / Revenue:
3.73x
PEG ratio (5yr expected):
--
EV / Free cash flow:
19.94x
Price / Operating cash flow:
17.48x
Enterprise value / EBITDA:
12.80x
Gross Profit (TTM):
$49.5B
Return On Assets:
11.53%
Net Income Margin (TTM):
17.5%
Return On Equity:
32.32%
Return On Invested Capital:
16.82%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-25 | 2023-12-25 | 2023-12-25 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $29.1B | $33.9B | $31.8B | $34.4B | $37.4B | |
| Total Assets | $84.5B | $95.4B | $90.9B | $93.8B | $106.6B | |
| Current Liabilities | $23.6B | $27.4B | $28.7B | $29.1B | $29.6B | |
| Total Liabilities | $47.9B | $50.4B | $60.6B | $60.1B | $70B | |
| Total Equity | $36.6B | $45B | $30.3B | $33.7B | $36.6B | |
| Total Debt | $15.8B | $16.3B | $29.1B | $28.2B | $38.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-25 | 2023-12-25 | 2023-12-25 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
RHHVF
Sector
Market Cap
$219.8B
$46.1M
Price % of 52-Week High
80.92%
46.02%
Dividend Yield
3.96%
0%
Shareholder Yield
2.81%
-0.6%
1-Year Price Total Return
0.12%
-30.52%
Beta (5-Year)
0.458
0.772
Dividend yield:
3.96%
Annualized payout:
$10.20
Payout ratio:
71.44%
Growth streak:
2 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$281.06
200-day SMA
Sell
Level
$286.49
Bollinger Bands (100)
Sell
Level
290.92 - 324.34
Chaikin Money Flow
Sell
Level
-688.8K
20-day SMA
Sell
Level
$284.50
Relative Strength Index (RSI14)
Sell
Level
35.40
ADX Line
Sell
Level
23.54
Williams %R
Neutral
Level
-77.6852
50-day SMA
Sell
Level
$295.77
MACD (12, 26)
Sell
Level
-4.56
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
1.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.9108)
Buy
CA Score
(Annual)
Level (-0.28)
Buy
Beneish M-Score
(Annual)
Level (-2.5965)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.329)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Stock Forecast FAQ
In the current month, RHHVF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RHHVF average analyst price target in the past 3 months is --.
-
Where Will Roche Holding AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Roche Holding AG share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Roche Holding AG?
Analysts are divided on their view about Roche Holding AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Roche Holding AG is a Sell and believe this share price will rise from its current level to --.
-
What Is Roche Holding AG's Price Target?
The price target for Roche Holding AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is RHHVF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Roche Holding AG is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of RHHVF?
You can purchase shares of Roche Holding AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Roche Holding AG shares.
-
What Is The Roche Holding AG Share Price Today?
Roche Holding AG was last trading at $275.83 per share. This represents the most recent stock quote for Roche Holding AG. Yesterday, Roche Holding AG closed at $275.83 per share.
-
How To Buy Roche Holding AG Stock Online?
In order to purchase Roche Holding AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
